|
Originally published In Press as doi:10.1074/jbc.M800333200 on April 3, 2008
J. Biol. Chem., Vol. 283, Issue 26, 17777-17788, June 27, 2008
Phorbol 12-Myristate 13-Acetate-dependent Protein Kinase C -Tyr311 Phosphorylation in Cardiomyocyte Caveolae*
Vitalyi O. Rybin,
Jianfen Guo,
Zoya Gertsberg,
Steven J. Feinmark, and
Susan F. Steinberg1
From the
Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032
Protein kinase C (PKC ) activation is generally attributed to lipid cofactor-dependent allosteric activation mechanisms at membranes. However, recent studies indicate that PKC also is dynamically regulated through tyrosine phosphorylation in H2O2- and phorbol 12-myristate 13-acetate (PMA)-treated cardiomyocytes. H2O2 activates Src and related Src-family kinases (SFKs), which function as dual PKC -Tyr311 and -Tyr332 kinases in vitro and contribute to H2O2-dependent PKC -Tyr311/Tyr332 phosphorylation in cardiomyocytes and in mouse embryo fibroblasts. H2O2-dependent PKC -Tyr311/Tyr332 phosphorylation is defective in SYF cells (deficient in SFKs) and restored by Src re-expression. PMA also promotes PKC -Tyr311 phosphorylation, but this is not associated with SFK activation or PKC -Tyr332 phosphorylation. Rather, PMA increases PKC -Tyr311 phosphorylation by delivering PKC to SFK-enriched caveolae. Cyclodextrin treatment disrupts caveolae and blocks PMA-dependent PKC -Tyr311 phosphorylation, without blocking H2O2-dependent PKC -Tyr311 phosphorylation. The enzyme that acts as a PKC -Tyr311 kinase without increasing PKC phosphorylation at Tyr332 in PMA-treated cardiomyocytes is uncertain. Although in vitro kinase assays implicate c-Abl as a selective PKC -Tyr311 kinase, PMA-dependent PKC -Tyr311 phosphorylation persists in cardiomyocytes treated with the c-Abl inhibitor ST1571 and c-Abl is not detected in caveolae; these results effectively exclude a c-Abl-dependent process. Finally, we show that 1,2-dioleoyl-sn-glycerol mimics the effect of PMA to drive PKC to caveolae and increase PKC -Tyr311 phosphorylation, whereas G protein-coupled receptor agonists such as norepinephrine and endothelin-1 do not. These results suggest that norepinephrine and endothelin-1 increase 1,2-dioleoyl-sn-glycerol accumulation and activate PKC exclusively in non-caveolae membranes. Collectively, these results identify stimulus-specific PKC localization and tyrosine phosphorylation mechanisms that could be targeted for therapeutic advantage.
Received for publication, January 14, 2008
, and in revised form, April 1, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grant HL77860 from NHLBI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: 630 West 168 St., New York, NY 10032. Tel.: 212-305-4297; Fax: 212-305-8780; E-mail: sfs1{at}columbia.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. F. Steinberg
Structural Basis of Protein Kinase C Isoform Function
Physiol Rev,
October 1, 2008;
88(4):
1341 - 1378.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|